We are pleased to announce that Setolabo LLC was selected for and participated in the “Program of America” under J-StarX,
a global startup development program organized by the Japan External Trade Organization (JETRO).
The program provided valuable opportunities to learn about cutting-edge innovations and business models in the U.S. healthcare and medical sectors.
During the program, Setolabo engaged in various professional exchanges, including meetings with experts from the American Cancer Society,
visits to the Japan Innovation Center and biotechnology laboratories, presentations to venture capital firms,
and discussions with insurance industry professionals.
Through these experiences, we explored new possibilities for advancing cancer testing technologies and healthcare innovation.
The program also included sessions on design thinking, teaming, business model development, and team building,
which offered practical insights through interaction with diverse experts and startup leaders.
Building on the knowledge and experience gained through J-StarX,
Setolabo will continue to promote medical innovation focused on the early detection of cancer
and strengthen collaboration with international partners to advance a Japan-origin preventive healthcare model on the global stage.